ChenGuang Biotech Group Toekomstige groei
Future criteriumcontroles 3/6
ChenGuang Biotech Group is forecast to grow earnings and revenue by 54.6% and 7.8% per annum respectively. EPS is expected to grow by 54.3% per annum. Return on equity is forecast to be 11.1% in 3 years.
Belangrijke informatie
54.6%
Groei van de winst
54.3%
Groei van de winst per aandeel
Food winstgroei | 22.1% |
Inkomstengroei | 7.8% |
Toekomstig rendement op eigen vermogen | 11.1% |
Dekking van analisten | Low |
Laatst bijgewerkt | 28 Oct 2024 |
Recente toekomstige groei-updates
Recent updates
A Piece Of The Puzzle Missing From ChenGuang Biotech Group Co., Ltd.'s (SZSE:300138) 43% Share Price Climb
Oct 08ChenGuang Biotech Group (SZSE:300138) Might Be Having Difficulty Using Its Capital Effectively
Sep 30Return Trends At ChenGuang Biotech Group (SZSE:300138) Aren't Appealing
May 13Impressive Earnings May Not Tell The Whole Story For ChenGuang Biotech Group (SZSE:300138)
Apr 25ChenGuang Biotech Group Co., Ltd. (SZSE:300138) Just Reported, And Analysts Assigned A CN¥17.66 Price Target
Apr 21Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 8,273 | 497 | N/A | N/A | 3 |
12/31/2025 | 7,402 | 368 | N/A | N/A | 4 |
12/31/2024 | 6,999 | 154 | N/A | N/A | 1 |
9/30/2024 | 6,927 | 150 | N/A | N/A | N/A |
6/30/2024 | 6,694 | 287 | N/A | N/A | N/A |
3/31/2024 | 6,786 | 389 | N/A | N/A | N/A |
12/31/2023 | 6,872 | 486 | N/A | N/A | N/A |
9/30/2023 | 6,669 | 496 | -146 | 33 | N/A |
6/30/2023 | 6,737 | 492 | 286 | 453 | N/A |
3/31/2023 | 6,529 | 462 | 489 | 627 | N/A |
12/31/2022 | 6,296 | 434 | 559 | 735 | N/A |
9/30/2022 | 6,465 | 429 | 291 | 478 | N/A |
6/30/2022 | 6,002 | 403 | 36 | 244 | N/A |
3/31/2022 | 5,446 | 380 | -587 | -329 | N/A |
12/31/2021 | 4,874 | 352 | -217 | 64 | N/A |
9/30/2021 | 4,410 | 322 | 59 | 407 | N/A |
6/30/2021 | 4,186 | 304 | 46 | 455 | N/A |
3/31/2021 | 4,188 | 285 | 225 | 715 | N/A |
1/1/2021 | 3,913 | 268 | 93 | 529 | N/A |
9/30/2020 | 3,667 | 252 | 272 | 667 | N/A |
6/30/2020 | 3,481 | 235 | 36 | 405 | N/A |
3/31/2020 | 3,288 | 206 | -170 | 88 | N/A |
12/31/2019 | 3,265 | 194 | -290 | -24 | N/A |
9/30/2019 | 3,226 | 165 | 70 | 292 | N/A |
6/30/2019 | 3,378 | 162 | 29 | 207 | N/A |
3/31/2019 | 3,139 | 146 | -196 | -37 | N/A |
1/1/2019 | 3,063 | 145 | -196 | -56 | N/A |
9/30/2018 | 2,799 | 155 | -536 | -381 | N/A |
6/30/2018 | 2,779 | 159 | N/A | -283 | N/A |
3/31/2018 | 2,807 | 155 | N/A | -176 | N/A |
12/31/2017 | 2,772 | 143 | N/A | -146 | N/A |
9/30/2017 | 2,780 | 129 | N/A | -55 | N/A |
6/30/2017 | 2,384 | 120 | N/A | -292 | N/A |
3/31/2017 | 2,259 | 111 | N/A | -354 | N/A |
12/31/2016 | 2,141 | 92 | N/A | -322 | N/A |
9/30/2016 | 1,824 | 99 | N/A | 125 | N/A |
6/30/2016 | 1,636 | 79 | N/A | 156 | N/A |
3/31/2016 | 1,474 | 80 | N/A | 44 | N/A |
12/31/2015 | 1,268 | 69 | N/A | -65 | N/A |
9/30/2015 | 1,246 | 59 | N/A | 54 | N/A |
6/30/2015 | 1,287 | 57 | N/A | 178 | N/A |
3/31/2015 | 1,205 | 24 | N/A | 209 | N/A |
12/31/2014 | 1,207 | 22 | N/A | 273 | N/A |
9/30/2014 | 1,238 | 21 | N/A | 266 | N/A |
6/30/2014 | 1,174 | 4 | N/A | 117 | N/A |
3/31/2014 | 1,131 | 3 | N/A | 38 | N/A |
12/31/2013 | 1,186 | 10 | N/A | -36 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: 300138's forecast earnings growth (54.6% per year) is above the savings rate (2.9%).
Winst versus markt: 300138's earnings (54.6% per year) are forecast to grow faster than the CN market (25.8% per year).
Hoge groeiwinsten: 300138's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: 300138's revenue (7.8% per year) is forecast to grow slower than the CN market (14% per year).
Hoge groei-inkomsten: 300138's revenue (7.8% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: 300138's Return on Equity is forecast to be low in 3 years time (11.1%).